Hi guys, PBT is my maiden Biotech stock, so excuse my inexperience in this question!
The fact that we have met our 100-patient target, and are looking at possibly adding more numbers, is this "the norm"? I mean, why do we need to put more people on the trial?
huntington's recruitment complete, page-6
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $59.43K | 20.64M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 64 | 110059224 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 17812681 | 6 |
View Market Depth
| Last trade - 11.58am 17/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |